Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links
Cat.#: ACPP-1545
| Despition | YWHAG Human Recombinant |
| SIZE | 5 µg |
| Purity | > 95.0% (SDS-PAGE) |
| Form | Sterile filtered colorless solution. |
| Storage | Store at 4°C for 2-4 weeks. |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1086 | Synthetic Nanodisc Human Somatostatin Receptor 2 Protein (AC1086) | 10 µg | inquiry |
| ACPP-1845 | Human GBA Protein (AC1845) | 2 µg | inquiry |
| ACPP-1681 | Human CALN1 Protein (AC1681) | 1 µg | inquiry |
| ACPP-1742 | Human PRND Protein (AC1742) | 2 µg | inquiry |
| ACPP-1292 | Nkx2.2 Blocking Peptide (AC1292) | 250 µg | inquiry |
| ACPP-1694 | Mouse FGF 1 Protein, His (AC1694) | 5 µg | inquiry |
| ACPP-1838 | Human APO D Protein, GST (AC1838) | 2 µg | inquiry |
| ACPP-1427 | Human ASMT Protein (AC1427) | 5 µg | inquiry |
| ACPP-1807 | Human QKI Protein (AC1807) | 2 µg | inquiry |
| ACPP-1631 | Human IMPDH1 Protein (AC1631) | 2 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.